Nicorandil prodrug (Unicycive Therapeutics)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameNicorandil prodrug (Unicycive Therapeutics)
Drug Alias NameUNI-494
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKATP channels activators
TargetsKATP channels
Therapy Area/IndicationsRenal Insufficiency, ChronicAcute Kidney Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSphaera Pharma
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, ChronicAcute Kidney Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A